mar-ondansetron tablet
marcan pharmaceuticals inc - ondansetron (ondansetron hydrochloride) - tablet - 4mg - ondansetron (ondansetron hydrochloride) 4mg - 5-ht3 receptor antagonists
mar-ondansetron tablet
marcan pharmaceuticals inc - ondansetron (ondansetron hydrochloride) - tablet - 8mg - ondansetron (ondansetron hydrochloride) 8mg - 5-ht3 receptor antagonists
auro-ondansetron injection solution
auro pharma inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists
auro-ondansetron injection solution
auro pharma inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists
auro-ondansetron injection solution
auro pharma inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists
apo-ondansetron
ipca pharma (nz) pty limited - ondansetron hydrochloride dihydrate 5mg equivalent to ondansetron 4 mg; - film coated tablet - 4 mg - active: ondansetron hydrochloride dihydrate 5mg equivalent to ondansetron 4 mg excipient: hypromellose iron oxide yellow lactose magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water titanium dioxide - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. also indicated for the prevention of post-operative nausea and vomiting
apo-ondansetron
ipca pharma (nz) pty limited - ondansetron hydrochloride dihydrate 10mg equivalent to ondansetron 8 mg; - film coated tablet - 8 mg - active: ondansetron hydrochloride dihydrate 10mg equivalent to ondansetron 8 mg excipient: hypromellose iron oxide yellow lactose magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water titanium dioxide - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. also indicated for the prevention of post-operative nausea and vomiting
apx-ondansetron ondansetron (as hydrochloride dihydrate) 4 mg tablet blister pack
arrotex pharmaceuticals pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.986 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; lactose; titanium dioxide; hypromellose; microcrystalline cellulose; triacetin - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.
apx-ondansetron ondansetron (as hydrochloride dihydrate) 8 mg tablet blister pack
arrotex pharmaceuticals pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.972 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; lactose; titanium dioxide; hypromellose; triacetin; iron oxide yellow - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.
ondansetron an odt ondansetron 4 mg orally disintegrating tablets blister pack
amneal pharma australia pty ltd - ondansetron -